Jazz Pharmaceuticals plc (JAZZ) Shares are Down -4.49%

Jazz Pharmaceuticals plc (JAZZ) has risen sharply, recording gains of 0.53% in the past 4 weeks. However, the stock has corrected -4.49% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 1.07% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.

The stock has recorded a 20-day Moving Average of 1.97% and the 50-Day Moving Average is 8.96%.The 200 Day SMA reached 10.78%


Jazz Pharmaceuticals plc (NASDAQ:JAZZ): The stock opened in the green at $123.07 on Friday, but the bulls found it difficult to push the prices higher. The stock reached a high of $123.58 and a low of $121.08 for the day. The stock did not find buyers even at the lows and closed at $121.48 recording a loss of -1.24%. 724,222 shares exchanged hands during the trading day. The stock had closed at $121.48 in the previous days trading.

Jazz Pharmaceuticals plc (JAZZ) : The consensus price target for Jazz Pharmaceuticals plc (JAZZ) is $184.18 for the short term with a standard deviation of $20.18. The most optimist securities analyst among the 11 who monitor the stock believes that the stock can reach $210, however, the pessimist price target for the company is $145.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.